These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30862043)

  • 1. Comparative Gene-Expression Analysis of Alzheimer's Disease Progression with Aging in Transgenic Mouse Model.
    Abid NB; Naseer MI; Kim MO
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30862043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology.
    Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C
    J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treadmill exercise inhibits the progression of Alzheimer's disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice.
    Liu HL; Zhao G; Zhang H; Shi LD
    Behav Brain Res; 2013 Nov; 256():261-72. PubMed ID: 23968591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.
    Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X
    Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traumatic Brain Injury Increases the Expression of Nos1, Aβ Clearance, and Epileptogenesis in APP/PS1 Mouse Model of Alzheimer's Disease.
    Miszczuk D; Dębski KJ; Tanila H; Lukasiuk K; Pitkänen A
    Mol Neurobiol; 2016 Dec; 53(10):7010-7027. PubMed ID: 26671618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset.
    Dionísio PA; Amaral JD; Ribeiro MF; Lo AC; D'Hooge R; Rodrigues CM
    Neurobiol Aging; 2015 Jan; 36(1):228-40. PubMed ID: 25443293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Neuropathological Effects of a High-Fat Diet in a Presymptomatic Alzheimer's Disease Stage in APP/PS1 Mice.
    Ettcheto M; Petrov D; Pedrós I; Alva N; Carbonell T; Beas-Zarate C; Pallas M; Auladell C; Folch J; Camins A
    J Alzheimers Dis; 2016 Jul; 54(1):233-51. PubMed ID: 27567882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRE1 signaling exacerbates Alzheimer's disease pathogenesis.
    Duran-Aniotz C; Cornejo VH; Espinoza S; Ardiles ÁO; Medinas DB; Salazar C; Foley A; Gajardo I; Thielen P; Iwawaki T; Scheper W; Soto C; Palacios AG; Hoozemans JJM; Hetz C
    Acta Neuropathol; 2017 Sep; 134(3):489-506. PubMed ID: 28341998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging, cortical injury and Alzheimer's disease-like pathology in the guinea pig brain.
    Bates K; Vink R; Martins R; Harvey A
    Neurobiol Aging; 2014 Jun; 35(6):1345-51. PubMed ID: 24360504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease.
    Weissmann R; Hüttenrauch M; Kacprowski T; Bouter Y; Pradier L; Bayer TA; Kuss AW; Wirths O
    J Alzheimers Dis; 2016; 50(2):397-409. PubMed ID: 26639971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression.
    Audrain M; Fol R; Dutar P; Potier B; Billard JM; Flament J; Alves S; Burlot MA; Dufayet-Chaffaud G; Bemelmans AP; Valette J; Hantraye P; Déglon N; Cartier N; Braudeau J
    Mol Neurodegener; 2016 Jan; 11():5. PubMed ID: 26759118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease.
    Reddy PH; McWeeney S; Park BS; Manczak M; Gutala RV; Partovi D; Jung Y; Yau V; Searles R; Mori M; Quinn J
    Hum Mol Genet; 2004 Jun; 13(12):1225-40. PubMed ID: 15115763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic diabetic states worsen Alzheimer neuropathology and cognitive deficits accompanying disruption of calcium signaling in leptin-deficient APP/PS1 mice.
    Zhang S; Chai R; Yang YY; Guo SQ; Wang S; Guo T; Xu SF; Zhang YH; Wang ZY; Guo C
    Oncotarget; 2017 Jul; 8(27):43617-43634. PubMed ID: 28467789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevating the Levels of Calcium Ions Exacerbate Alzheimer's Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau.
    Guan PP; Cao LL; Wang P
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease.
    Völgyi K; Badics K; Sialana FJ; Gulyássy P; Udvari EB; Kis V; Drahos L; Lubec G; Kékesi KA; Juhász G
    Mol Neurobiol; 2018 Oct; 55(10):7839-7857. PubMed ID: 29468564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid and tau pathology of familial Alzheimer's disease APP/PS1 mouse model in a senescence phenotype background (SAMP8).
    Porquet D; Andrés-Benito P; Griñán-Ferré C; Camins A; Ferrer I; Canudas AM; Del Valle J; Pallàs M
    Age (Dordr); 2015 Feb; 37(1):9747. PubMed ID: 25663420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Pedrós I; Petrov D; Allgaier M; Sureda F; Barroso E; Beas-Zarate C; Auladell C; Pallàs M; Vázquez-Carrera M; Casadesús G; Folch J; Camins A
    Biochim Biophys Acta; 2014 Sep; 1842(9):1556-66. PubMed ID: 24887203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
    España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
    Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Amyloid and the Pathomechanisms of Alzheimer's Disease: A Comprehensive View.
    Penke B; Bogár F; Fülöp L
    Molecules; 2017 Oct; 22(10):. PubMed ID: 28994715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.